Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-09

Clinical Trial Update: EXPAREL for Minimally Invasive Supracervical Hysterectomies [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for EXPAREL in pain management following minimally invasive supracervical hysterectomies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2024-01-09